Inovio Pharmaceuticals.
American biotechnology company
- Reports this week
- 1
- Active events
- 1
- Connections
- 39
What's happening
Active this week
One to three months ago
-
Inovio Pharmaceuticals received reports on company developments and is being tracked by financial blogs Benzinga and MarketBeat.Some support3 reports
-
Inovio Pharmaceuticals and Pyxis Oncology are both small-cap healthcare companies.Some support1 report
-
Inovio Pharmaceuticals and Synlogic, Inc. are identified as competing small-cap healthcare companies.Some support2 reports
-
Inovio Pharmaceuticals and Generate Biomedicines Inc are two healthcare companies that are currently being compared for potential investment.Some support1 report
Gone quiet
No new reports in 90+ days-
Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.Speculative2 reports
-
Inovio Pharmaceuticals is scheduled to present at the Orphan Drug Summit in Boston on July 8, 2025.Speculative1 report
No events began in the chosen period. Widen it, or reset.
Around Inovio Pharmaceuticals this week
News at the entities that move Inovio Pharmaceuticals most-
FDA StructuralFDA approval coincided with Donald Trump's press conference on November 11, 2026.Moves Inovio Pharmaceuticals
-
Jefferies Financial Group Mentioned togetherAlabama retirement systems lowered their position while Amundi increased its stake and Jefferies issued a hold rating.Moves Inovio Pharmaceuticals
-
Securities and Exchange Commission StructuralDanaher Corporation disclosed filings with the SEC, and Fifth Third Bancorp reduced its position in Danaher.Moves Inovio Pharmaceuticals
-
MarketBeat Mentioned togetherMultiple financial institutions, including RBC, UBS, and Citi, issued rating and price target updates for Addus HomeCare Corporation on November 12, 2026.Moves Inovio Pharmaceuticals
-
Pennsylvania Shared contextMultiple Pennsylvania politicians, including Madeleine Dean and Chris Deluzio, are considering challenging John Fetterman for the Senate seat.Moves Inovio Pharmaceuticals
-
Benzinga Mentioned togetherCullinan Therapeutics stock is listed on Nasdaq, as reported by Benzinga.Moves Inovio Pharmaceuticals
Connections
The 10 strongest of 39, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Mike Sumner Structural
Mike Sumner holds the position of Chief Medical Officer at Inovio Pharmaceuticals.
-
FDA Structural
FDA regulates Inovio Pharmaceuticals, granting designations and approvals for its pharmaceutical products.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides investment ratings and price targets for Inovio Pharmaceuticals.
-
Securities and Exchange Commission Structural
Inovio Pharmaceuticals is formally regulated by the Securities and Exchange Commission.
-
MarketBeat Mentioned together
MarketBeat tracks and reports analyst recommendations regarding Inovio Pharmaceuticals.
-
Ernst & Young LLP Structural
Shareholders approved Ernst & Young LLP to serve as the independent registered public accounting firm for Inovio Pharmaceuticals.
-
Pennsylvania Shared context
Inovio Pharmaceuticals is based in the state of Pennsylvania.
-
Benzinga Mentioned together
Benzinga functions as a financial news service that covers and reports on company developments regarding Inovio Pharmaceuticals.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
1 eventSeptember 2026
2 eventsShow 2 earlier months
August 2026
1 eventJune 2026
3 events- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.
- Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.
- Inovio Pharmaceuticals is scheduled to present at the Orphan Drug Summit in Boston on July 8, 2025.